Tazobactam/ceftolozane (TAZ/CTLZ) and relebactam/imipenem (REL/IPM) susceptibility in Japan: Nationwide surveillance of respiratory bacterial pathogens in 2019/20
Abstract
Tazobactam/ceftolozane (TAZ/CTLZ) and relebactam/imipenem/cilastatin (REL/IPM/CS) are expected to be effective for treating patients with antimicrobial-resistant infections, particularly gram-negative pathogens, but nationwide surveillance of these has not been investigated thoroughly in Japan. Pseudomonas aeruginosa (n = 164), Klebsiella pneumoniae (n = 141), and Haemophilus influenzae (n = 156) isolated from respiratory infected patients in Japan from June 2019 through December 2020 provided by the Japanese Surveillance Committee were used. Antimicrobial susceptibility testing for TAZ/CTLZ, REL/IPM and comparator agents against isolates were carried out by broth microdilution methods according to the Clinical and Laboratory Standards Institute standard. The MIC50/90 of TAZ/CTLZ against P. aeruginosa and K. pneumoniae were 0.5/1 μg/mL and 0.25/0.5 μg/mL, those of REL/IPM were 0.25/1 μg/mL and 0.25/0.5 μg/mL, respectively, and all isolates were susceptible to both drugs. Susceptible rates for P. aeruginosa to IPM, ceftazidime (CAZ), and levofloxacin (LVFX) were 84.1, 87.8, and 76.8 %, and those of K. pneumoniae to tazobactam/piperacillin, CAZ, and LVFX were 98.6, 98.6, and 95.0 %, respectively. The MIC50/90 of TAZ/CTLZ for H. influenzae were 0.5/2 μg/mL, comparable to those of cefepime (CFPM), 1/2 μg/mL, but susceptible rate to TAZ/CTLZ and CFPM differed at 50.6 and 100 %, respectively. This difference was estimated from the different clinical breakpoints between TAZ/CTLZ…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.